24/7 MN – (NASDAQ: GLSI) GREENWICH LIFESCIENCES INC. shares are up 10% on light volume in pre-market trading. The company announced they can proceed with phase 3 trials. The stock is $9.37 a share and has more than 1777 trades this summer morning.

July 12, 2022

[mstock id=”73007″ asset=”glsi”]

Greenwich LifeSciences Announces Removal of Clinical Hold Permitting Phase III Clinical Trial to Proceed

https://www.businesswire.com/news/home/20220712005542/en/Greenwich-LifeSciences-Announces-Removal-of-Clinical-Hold-Permitting-Phase-III-Clinical-Trial-to-Proceed

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.